HCG | Healthcare Consultancy Group

Fueled for Healthcare

Being fueled demands 3 things that work as one: a trusted partnership, passion, and kinetic energy. Working together and fueled by passion and kinetic energy, we are much stronger than we are as individuals. The Healthcare Consultancy Group (HCG), part of the Omnicom Health Group, is a global family of scientifically rigorous healthcare communications agencies.

Fueled by a Trusted Partnership

We are a trusted partnership of highly degreed, remarkably intelligent professionals, driven by innovation and collaboration, to create platforms that introduce our clients’ ideas to the world in a bold, new way.

Fueled by Passion

We never lose sight of the importance of bringing our clients’ medicines closer to the patients who need them. It’s what drives us.

Fueled by Kinetic Energy

We are 11 companies, trusted partners, with the skills and resources to deliver in a big way, regardless of the size and scope of the job. For us, every project is the big one.

See Our Companies

Who We Are

  • Guided by the principles of accuracy and truthfulness, Accuverus develops scientific content for busy healthcare professionals around the globe. We work hand-in-glove with clients of all sizes to disseminate cutting-edge data about pharmaceutical products, devices, nutraceuticals, and healthcare procedures across numerous therapeutic areas. Our scientists, all bench trained, work with medical experts to develop state-of-the-art content for publications and programs to educate other healthcare providers.

    Supporting our scientists are seasoned staff trained in various educational techniques, principles of adult learning, health literacy, and medical editing—all working to ensure that accurate communications are truly targeted to the audience you want to reach.

    www.accuverus.com

    President
    Mary Rofael, MD
    mrofael@hcg-int.com
    (216) 262-4554
    ADDRESS
    Accuverus
    25101 Chagrin Boulevard
    Suite 230
    Beachwood, OH 44122
  • Chameleon has a 20-year heritage as a groundbreaking and entrepreneurial global medical communications agency. We have teams of experienced and dedicated experts for the development and execution of scientific and marketing communications across all channels and markets. We work with leading client teams on the most stimulating and challenging programs in the world of healthcare.

    With our digital arm, Entwine, we are leaders in creating new ideas and approaches that revolutionize the market. Driven by tools that personalize education, maximize the impact of data, and provide patient-centered and outcomes-oriented solutions, Chameleon can be the difference.

    www.chameleon-uk.com

    Group Chairman
    Gary Hobbs
    ghobbs@hcg-int.com
    +44 (208) 326-3151
    ADDRESS
    Chameleon Communications International, Ltd.

    Central London
    Bankside 2
    90-100 Southwark Street
    London
    SE1 0SW

    West London
    40–44 Uxbridge Road
    London
    W52BS
    UK

    Manchester
    50 Alderley Road
    Wilmslow
    Cheshire SK9 1NY
    UK

    New York
    488 Madison Avenue, 5th floor
    New York, NY 10022

    New Jersey
    485 Route 1 South
    Building C
    Suite C-120
    Iselin, NJ 08830

    Los Angeles
    12777 West Jefferson Boulevard
    Building C
    Los Angeles, CA 90066

  • With a presence in London and New York, Entwine is a global digital innovation agency and the fastest growing part of the Healthcare Consultancy Group. We aim to seamlessly integrate digital resources, scientific content, and data layers that are meaningful to healthcare stakeholders into solutions answering their real-world needs. Our digital communications strategies are designed to have a positive, practical impact on the everyday lives of our clients, HCPs, and patients, while our solutions, whether they are digital ecosystems, tools, or cutting-edge technologies, are designed to make the interactions with science and data exciting and memorable.

    entwine.healthcare

    PRESIDENT
    Karl Simunic, MS
    ksimunic@hcg-int.com
    +44 (208) 326-3177
    ADDRESS
    Entwine

    West London
    40-44 Uxbridge Road
    Ealing, London
    W52BS
    UK

    New York
    488 Madison Avenue, 5th Floor
    New York, NY 10022
    USA

    Manchester
    50 Alderley Road
    Wilmslow
    Cheshire SK9 1NY
    UK

  • Health Science Communications (HSC) is an innovative agency that provides medical strategy and educational initiatives to pharmaceutical, biotech, and device companies. We do this with a blend of scientific integrity and cutting-edge communications tools.

    At HSC we share a talent for translating scientific promise into clinical reality and accelerating product adoption. Our large team of medical directors and marketing and creative experts maximizes the value of brands through market-shifting initiatives while maintaining customers’ trust.

    www.hsci.com

    CEO
    Delphine Dubois, MD, MBA
    ddubois@hcg-int.com
    (212) 849-7910

    PRESIDENT
    Jan-Willem van Doorn, MD, PhD, MBA
    jvandoorn@hcg-int.com
    (212) 849-7715
    ADDRESS
    Health Science Communications
    488 Madison Avenue, 5th floor
    New York, NY 10022
  • At Health Science Communications New Jersey,* no assignment is too big or too small. We have the medical acumen and the strategic dexterity to creatively solve your brand’s challenges in both traditional and novel ways. We are committed to remaining at the forefront of adult learning, translating theory into practice to create meaningful, whole-brain learning experiences for physician, allied health, and patient learners.

    www.healthsciencecommunications-nj.com

    *Formerly BlueSpark Healthcare Communications.

    CEO
    Delphine Dubois, MD, MBA
    ddubois@hcg-int.com
    (732) 621-2802

    PRESIDENT
    Jan-Willem van Doorn, MD, PhD, MBA
    jvandoorn@hcg-int.com
    (212) 849-7715
    ADDRESS
    Health Science Communications New Jersey
    485 US Route 1 South
    Building C
    Suite C-120
    Iselin, NJ 08830
  • Hyphen Digital (HD) is an adaptable, forward-thinking healthcare agency with an unparalleled ability to merge state-of-the-art digital creative with medical science.

    When it comes to digital creative and strategy, we’ve done it all. But at HD, we’re most excited about doing things that no one has ever seen before. Let’s create something new together.

    www.hyphendigital.com

    PRESIDENT
    Gregory Imber
    gimber@hcg-int.com
    (212) 849-7721
    ADDRESS
    Hyphen Digital

    New York
    488 Madison Avenue, 5th floor
    New York, NY 10022

    Connecticut
    1055 Washington Boulevard
    7th floor
    Stamford, CT 06901

    New Jersey
    485 Route 1 South
    Building C
    Suite C-120
    Iselin, NJ 08830

    California
    55 Union Street, 3rd floor
    San Francisco, CA 94111

  • ProEd helps life sciences companies communicate data in compelling ways that matter to healthcare providers, the patients they treat, the regulators who protect them, and the payers who control access to therapies. Our passion and energy help accelerate product approvals, increase physicians' and healthcare providers' understanding, and improve patient access to the latest advancements in medicine.

    We become trusted partners to our clients. Our teams match their scientific rigor, strategic focus, and creative inspiration with the operational diligence to deliver on our promises.

    www.proedcom.com

    PRESIDENT
    Mary Rofael, MD
    mrofael@hcg-int.com
    (216) 262-4554
    (216) 595-7919
    ADDRESS
    ProEd

    Ohio
    25101 Chagrin Boulevard
    Suite 230
    Beachwood, OH 44122

    New York
    488 Madison Avenue, 5th floor
    New York, NY 10022
    USA

  • ProEd regulatory is the industry’s leading full-service provider of Health Authority Meeting readiness. Our team excels in preparing companies to present compelling and credible arguments to FDA advisory committees. The average healthcare company will take 2 drugs a year through regulatory proceedings. We’ll take 8 to 10, and with a success rate of >80%, we bring our clients a unique advantage from day one.

    It’s an advantage built on the pillars of (1) science and strategy, (2) communications and training, and (3) planning and process. Our team can help you create and deliver messages that cut across medical and scientific disciplines, transcend preconceived notions, and withstand regulatory scrutiny. Our regulatory and development consultants provide the guidance needed at all of the critical junctures of a product’s life cycle. And our outstanding operations, medical writing, and technical teams offer unmatched, seamless, end-to-end support that constantly wins client and clinical expert praise.

    www.proedregulatory.com

    PRESIDENT
    Mary Rofael, MD
    mrofael@hcg-int.com
    (216) 262-4554
    (216) 595-7919

    EVP, REGULATORY COMMUNICATIONS
    Greg Connel
    gconnel@hcg-int.com
    (216) 378-8860
    ADDRESS
    ProEd Regulatory
    25101 Chagrin Boulevard
    Suite 230
    Beachwood, OH 44122
  • Provaluate is a boutique market access consultancy and execution partner, committed to enhancing your business and differentiating your products in the eyes of access decision-makers and influencers. We partner with leading-edge life science companies to bring an innovative approach to the market access conversation. Provaluate combines former industry strategists and marketers with experienced medical communications professionals. This highly specialized team brings a deep understanding of rare and specialized disease states. Provaluate is part of the Healthcare Consultancy Group and Omnicom Health Group.

    EVP, MANAGING DIRECTOR
    Scott Roberts, MBA
    sroberts@hcg-int.com
    (216) 378-8855
    ADDRESS
    Provaluate
    25101 Chagrin Boulevard
    Suite 230
    Beachwood, OH 44122

  • The Scienomics Group (TSG) Carbon is a highlight-specialized, innovative, and impactful force in scientific and medical strategic education, leveraging our deep bench of in-house PhDs to facilitate scientist-to-scientist discussions around the clinical value proposition of our clients' therapies. Our group of medical affairs specialists partner with clients in cutting-edge ways to maximize engagements with their key audiences to provide scientific discussions that enlighten and shift mindsets. We are committed to the integrity of our clients' data, and our partnerships result in effective, compelling, and strategic scientific insights that enlighten the clinical rationale for their therapies. We pride ourselves on being our clients’ medical affairs scientific partner of choice.

    www.scienomicscarbon.com

    PRESIDENT
    Lauren Pattani-Wright, MBA
    lpattani-wright@hcg-int.com
    (203) 992-6732
    ADDRESS
    Scienomics Carbon

    Connecticut
    1055 Washington Boulevard
    7th floor
    Stamford, CT 06901

    California
    55 Union Street, 3rd floor
    San Francisco, CA 94111

    New York
    488 Madison Avenue, 5th floor
    New York, NY 10022

    New Jersey
    485 Route 1 South
    Building C
    Suite C-120
    Iselin, NJ 08830

  • For over 15 years, The Scienomics Group (TSG) Catalyst has been an industry leader in scientific and medical strategic communications. We are an experienced team of marketing, digital, and creative professionals, with a deep bench of in-house PhDs, all of whom are committed to partnership and united by a shared purpose of helping our clients commercialize their breakthrough therapies. Through innovative, digital, and interactive platforms, we are able to facilitate effective peer-based scientific dialogue that brings HCPs to understand our clients' therapies’ scientific stories for better treatment decisions and patient outcomes. By harnessing our scientific insights, creativity, and deep healthcare marketing expertise, we are able to uniquely communicate the scientific basis and clinical rationale for their new therapies.

    www.scienomicscatalyst.com

    PRESIDENT
    Lauren Pattani-Wright, MBA
    lpattani-wright@hcg-int.com
    (203) 992-6732
    ADDRESS
    Scienomics Catalyst

    Connecticut
    1055 Washington Boulevard
    7th floor
    Stamford, CT 06901

    California
    55 Union Street, 3rd floor
    San Francisco, CA 94111

    New York
    488 Madison Avenue, 5th floor
    New York, NY 10022

    New Jersey
    485 Route 1 South
    Building C
    Suite C-120
    Iselin, NJ 08830








Leadership

Global Leadership Counsel

  • Matt D’Auria
    Chief Executive Officer, Healthcare Consultancy Group
    PHONE
    (203) 992-6703

    Matt D’Auria brings more than 20 years of strategic marketing and healthcare communications experience to his role as CEO of the Healthcare Consultancy Group (HCG), where he drives the fusion of strategy, scientific rigor, creativity, and digital innovation that distinguishes the HCG agencies as world-leading medical communications firms. Matt’s belief is that acquiring and developing the best talent is key to the success of HCG; he places a strong point of emphasis on employee engagement, building cohesive client teams, and maintaining a culture defined by inclusiveness and collaboration.

    Prior to assuming leadership of the group, Matt was president of The Scienomics Group, one of HCG’s foundational medical communications agencies. His clients benefit from his unique blend of marketing expertise, scientific knowledge, and specialty therapeutic area experience. Matt has worked extensively in oncology, hematology, urology, mental health, and metabolic disorders.

    Prior to his career in medical communications, Matt gained a deep understanding of the industry from a client-side perspective with prior experience in brand management and sales for AstraZeneca and Solvay Pharmaceuticals. Matt has been involved in branding and commercialization strategies at every point in the drug development life cycle.

    Matt has a profound respect for the science behind today’s innovative medicines. His career began in the laboratory as a bench scientist, studying signal transduction pathways in diabetes mellitus. A graduate of the University of California, Berkeley, with a BS in molecular and cell biology, Matt continued his education and received an executive certificate in pharmaceutical drug development from UC Berkeley’s Haas School of Business.

    Matt is a novice wine collector with a particular fondness for a well-aged Barolo. He enjoys cooking and is happiest when his kitchen is full with family and close friends.

  • Brian Kielty
    Global Chief Financial Officer
    Chief Operating Officer
    Healthcare Consultancy Group
    PHONE
    (212) 849-7956

    Brian came to the Healthcare Consultancy Group (HCG) in 2001 through his work with Arthur Andersen LLP as a CPA. While there, he managed business advisory engagements with some of the world’s most prestigious organizations, ranging from consumer packaged goods to advertising firms, including HCG’s parent, Omnicom Group, Inc.

    While at Andersen, Brian developed a track record for excelling in client service; he understands the needs of clients, how to cultivate talent, and how to assemble best-in-class teams to deliver efficient, high-value service within each client engagement. Since assuming financial and operational roles within HCG, Brian has drawn on this experience extensively, to the benefit of both his internal- and external-facing responsibilities as HCG’s global CFO and COO.

    Today, HCG's clients work closely with Brian to create value through optimization, efficiency, and the development of new ways of operating. In no industry, perhaps, is this more relevant than in the healthcare sector. Brian has been a partner to both our big pharmaceutical and small biotech clients in overcoming the challenges they increasingly face with regard to financial scarcity and a general deleveraging of a legacy infrastructure built on the backs of blockbuster, mass-market products.

    Brian’s current passion outside of work centers around everything “kids.” Process optimization and efficiency do not seem to be at the forefront of his 3 small boys’ agenda.

  • Denise Bottiglieri, PhD
    Global Chairwoman, Healthcare Consultancy Group
    PHONE
    (212) 849-7935

    Denise Bottiglieri, PhD, is a seasoned executive with over 30 years’ experience in healthcare. She has built companies from the ground up and grown companies both internationally and domestically that serve the biotech and pharmaceutical industry. She has a wealth of experience bridging prelaunch, perilaunch, and postlaunch strategic and tactical digital and traditional communications and initiatives. Relishing a challenge, Denise is accustomed to working and succeeding in ambiguous environments.

    Denise is currently the global chairwoman of the Healthcare Consultancy Group (HCG). Prior to her promotion to global chairwoman, she served as global CEO of HCG for 15 years. In addition to her current role on the executive management team at HCG, she has assumed responsibilities within Diversified Agency Services (DAS), focusing on growth and innovation in healthcare.

    Denise earned her PhD in pharmacology from the University of Florida and completed her postdoctoral training in clinical pharmacology at Vanderbilt University. She went on to work in Pfizer’s New York headquarters, where, as director of drug development, she was instrumental in the design and execution of multinational clinical trials.

    Denise is passionate about providing opportunities for veterans and supports organizations dedicated to identifying and treating PTSD and traumatic brain injury. She serves on the board of the SEAL Future Fund, and in 2014 Denise started the Accelerate Program, the first-ever Special Operations Forces veterans’ transition program at DAS. In addition, she is a strong advocate for animal rights, an avid boxing fan (traditional, not UFC), and at one time wanted to be a physicist, but Maxwell’s demon got the best of her. Denise lives in Connecticut with her 4 dogs—Monster, Tyson, Layla, and Roxy—and her partner, Ed. They are currently looking for the fifth member of the pack.









Leadership

  • Delphine Dubois, MD, MBA
    Chief Executive Officer, Health Science Communications
    PHONE
    (212) 849-7910

    Delphine discovered the exciting world of scientific communications and advertising while working on the launch of Proscar for Merck in France. Following her marketing and advertising experience in Europe, she moved to the US and developed scientific communications for multiple drug launches as a medical director. Before becoming involved with medical education and advertising, Delphine was a family physician in private practice in Paris. She received her MD from the University of Paris, Faculté de Médecine Saint-Antoine. In addition to her medical degree, she also has an MBA with a specialty in medical marketing from the Ecole Supérieure de Commerce de Paris.

    Through her 20 years of experience, she has perfected her ability to build strategic roadmaps for new brands, linking the scientific evidence to the challenging marketplace. Delphine is a master at finding leverage points for her clients. Whether it’s identifying how to best shape the market, mining clinical data to uncover competitive differentiation, or creating programs that generate strong advocacy across the medical/scientific community, she zeroes in on opportunities to best maximize a brand's advantage. She's relentless in her pursuit of smart, strategic solutions and she lets nothing get in the way of doing what's best for her clients. More than anything, Delphine makes things happen—for her clients, for her agency, and for all who work with her.

    Despite her successful career in the US, she will never give up French wine and bread and celebrating Bastille Day.









  • Mary Rofael, MD
    President, ProEd Communications Inc.
    PHONE
    (216) 262-4554

    A communications counselor and strategist, Mary Rofael, MD, has more than 20 years’ experience leading medical affairs, publications, and regulatory communications programs for innovative pharmaceutical, medical device, and biotechnology companies.

    In the course of this work, Mary has led the assessment of drug development plans and data for an extensive portfolio of therapies across numerous therapeutic areas and strategic challenges. She has evaluated data packages to identify and address potential clinical and regulatory hurdles, worked with clients to build credible and compelling messages and presentations, and trained client teams to manage issues and handle objections. She is an experienced facilitator with a focus on moderating communication strategy sessions.

    Since 1998, Mary has served in several positions within ProEd. She founded ProEd’s regulatory division and, as medical director and chief strategic and regulatory officer, served as a trusted partner to more than 120 pharmaceutical, biotechnology, and medical device clients as they prepared for FDA advisory committee meetings, EU oral hearings, and other critical regulatory interactions. Over 16 years, Mary built a team of in-house scientists and regulatory experts, designers and technology specialists, speaker coaches, and program managers who provide full-service support for FDA advisory committee and other critical regulatory interactions. As head of scientific services, she provided strategic direction, scientific consulting, and oversight for a division of ProEd that has developed and maintained more than 125 medical publication plans overall, and annually supports the development of more than 350 print and digital projects, including manuscripts, medical abstracts, and posters designed to improve patient outcomes.

    Most recently, Mary served as chief strategic officer for the Healthcare Consultancy Group (HCG), developing communications strategies and solutions for clients of ProEd and its fellow HCG agencies to address the ever-increasing medical information needs of physicians and patients.

    As president of ProEd Communications Inc., Mary directs ProEd’s industry-leading medical affairs, publications, and regulatory communications divisions as well as the firm’s growing market access and development consulting services. She leads teams of MDs. PhDs, and PharmDs, client service professionals, designers, and communications coaches to address their clients’ needs across audiences and therapeutic areas.

  • Gary Hobbs
    Group Chairman, Chameleon Communications International, Inc.
    PHONE
    +44 (208) 326-3151

    Gary is the group chairman of Chameleon, a leading medical communications company with offices in west and central London, Manchester, New York, New Jersey, and Los Angeles. Chameleon specializes in providing leading-edge strategic and advisory services and global and regional communications programs. These incorporate scientific and marketing communications, professional education, and captivating interactive digital programs, all with the intent of building the scientific platform upon which successful pharmaceutical brands are founded. Gary believes that effective business leadership is most simply about "positively influencing the course of events" and tries to live up to this day by day.

    Gary graduated in physiology and biochemistry from the University of Southampton and found his way into the healthcare arena with Bayer Pharmaceuticals in the UK. Gary progressed through sales and sales management to marketing, where he led the team responsible for the launch of ciprofloxacin (Cipro/Ciproxin). This experience brought Gary into contact with the world of medical communications, and after 11 years at Bayer he moved to Franklin Scientific Projects, a medical education agency within DMB&B. It was here where, as managing director, he gained a lifelong interest in helping groups of people excel in achieving their business goals and in growing their teams and careers as a result.

    Gary brought this philosophy to Chameleon in 2001, via a 2-year spell as CEO of Medical Action Communications. Since then, he has enjoyed the enormous satisfaction of seeing the accumulated hard work and talent of the evolving Chameleon team come to fruition to make Chameleon the company it is today.

    Chameleon has a range of clients, from small biotech to large pharma, but the common denominator is the passion with which Chameleon identifies the route by which its clients can succeed and the vigor with which Chameleon pursue that goal. Clearly, this is highly valued by clients, since loyalty is a theme of Chameleon's client relationships, some of which (Novartis) date back to Chameleon's inception in 1997 and others, such as Bayer, which date back to 2002.

    Outside of work, Gary enjoys spending time with his family; watching his football (soccer) team, Tottenham Hotspur; and seeing Bruce Springsteen perform live (more than 50 times since 1981!).

  • Bill Mulligan
    Group Chief Executive Officer, Chameleon Communications International, Inc.
    PHONE
    (212) 680-9103

    Bill is currently Chief Executive Officer of the Chameleon group, where he manages all aspects of the agency and oversees a variety of clients, from large pharmaceutical companies to biotech startups. Chameleon is a full-service medical education provider with exceptional strength in content development for specialized therapeutic categories.

    Bill received a BS degree from Syracuse University in Syracuse, New York, and an MBA from the University of Delaware in Newark, Delaware. He started his career at Carrafiello Diehl and Associates, where he was fully immersed in the concept of integrated marketing, working on consumer, trade, and medical campaigns. This work set the foundation for a career dedicated to strategic planning to drive media-neutral campaigns and build success for clients.

    The depth and breadth of Bill's healthcare experience was firmly established through his 9 years at Medicus/DMB&B, where he rose to the position of EVP, managing director of the New York office. While at Medicus, Bill was responsible for the creation and successful promotion of the agency's global marketing and branding operations, launching healthcare brands in over 40 markets worldwide. After Medicus, Bill served as a senior partner at JWT and then as COO/general manager of Ogilvy Healthworld.

    With a deep understanding of both sides of the healthcare equation—consumers and healthcare professionals—Bill has extensive experience in all phases of communications, including strategic planning and integrated program development on a domestic as well as global basis.

    Bill lives in Darien, Connecticut, with his wife, Wendy; 3 children; and too many dogs. Boating, gardening, and golf are his part-time passions. With a name like Mulligan, he should be a better golfer, but he’s not.

  • Stephen Marchant
    President, Group Strategy and Growth, Chameleon Communications International, Ltd Europe
    PHONE
    +44 (208) 326-3148

    Stephen joined Chameleon in 2004 as editorial director, but over the next few years he found himself transitioning more and more into client service and management roles, first heading up a client service team and eventually being appointed commercial director, then president of the London office, and finally president of the European operation.

    Chameleon EU has a range of global pharma clients, predominantly based in Europe, and accounts that span early prelaunch products to those in life-cycle management.

    Stephen graduated from the University of Leeds with a degree in physiology, specializing in neuroscience, and, after some experience working in marketing, found his way into medical communications as a medical writer at Wells Medical. He spent the next several years writing across multiple therapeutic areas and disciplines at Medicus International, Discovery London, and Parexel.

    Stephen’s focus at Chameleon is putting the team and clients at the heart of what they do, and energizing the teams to provide the cutting-edge strategy, service, and creativity on which Chameleon bases its reputation. Externally, Stephen has been contributing to the CSpirit community engagement program, with specific emphasis on diversity and inclusion, CSR, and charitable giving.

    Outside of work, Stephen enjoys spending time with his family, exploring the great outdoors, and climbing mountains with like-minded friends, while wearing dinner suits in an endeavor known as extreme dining.

  • Jan-Willem van Doorn, MD, PhD, MBA
    President, Health Science Communications
    PHONE
    (212) 849-7715

    Jan-Willem brings broad experience and expertise in the healthcare and life sciences industries to the Healthcare Consultancy Group. He began his career in clinical research in orthopedics after completing his medical degree at the University of Amsterdam. His research culminated in a PhD in medicine from Gothenburg University. Enjoying the business side of medicine, he completed an MBA at NYU’s Stern School of Business with honors (Beta Gamma Sigma). Before making the switch to medical strategy scientific communications, Jan-Willem helped establish The Spine Center at the Hospital for Joint Diseases and sharpened his strategic and marketing acumen through management consulting with Booz Allen Hamilton and Campbell Alliance.

    Leveraging his broad experience and expertise, Jan-Willem enjoys finding solutions for the diverse and complex challenges that HSC's pharmaceutical, biotech, and medical device clients are facing. He takes a holistic approach to issues, weighing the viewpoints of all stakeholders and their importance to create a complete picture. The insights derived this way enable him and his team to develop the best client solutions in a rapidly changing environment. It allows clients to break through their organizational silos and develop integrated solutions for their brands. In pursuit of the best scientific strategy, he follows Michael Porter’s maxim: "The essence of strategy is choosing what not to do."

    Guided by Jan-Willem, HSC's purpose-built teams have demonstrated a unique ability to help their clients translate the science of their products and the pathogenesis of associated diseases into clinically relevant and scientifically accurate information understandable by the target audience. Translation of the science is the basis of a scientific platform and development of a scientific brand, and crucial to successful new product launches and life-cycle management.

    Jan-Willem regularly travels back to his home country, the Netherlands, to visit family, buy Dutch cheese and licorice, and watch his favorite sport, field hockey.

  • Lauren Pattani-Wright, MBA
    President, The Scienomics Group
    PHONE
    (203) 992-6732

    Lauren brings over 15 years of experience in the healthcare industry, 12 of which she spent on the client side in marketing, leading global teams to launch compounds in both highly specialized and primary care therapeutic areas. As president of The Scienomics Group (TSG), Lauren sets the tone and culture that drive the company’s commitment to high science, married to elegant and visionary creative quality, implemented across a multitude of change-making innovative platforms for all clients, from launch to compound expiry.

    Lauren launched TSG’s San Francisco office in 2009 and reinforces bicoastal client support by ensuring TSG maintains and expands its deep bench of scientific experts, client-focused marketers and project managers, creative artists, and digital leaders. Having experienced on the client side how true collaborative agency partnerships translate into groundbreaking successful product launches, Lauren reinforces TSG’s vision of strong client empathy, understanding, and connection to client-driven success.

    Prior to joining TSG, Lauren held leadership positions in marketing, leading several commercial launches and developing postapproval marketing strategies, including KOL development and engagement, scientific communications, branding and brand positioning, and targeted medical education strategy directed toward multiple healthcare provider audiences.

    Lauren’s biggest passion is the professional development and mentoring of professional women of color; she has spearheaded the Healthcare Consultancy Group Women of Color Mentoring Program for the past 8 years. Lauren received her BA in economics and French at the University of Virginia and her MBA in marketing and finance from Columbia Business School.

    From classical piano to classic hip hop, Lauren loves music and works it into every holiday party celebration!

  • Gregory Imber
    President, Hyphen Digital (HD)
    PHONE
    (212) 849-7721

    During his career, Greg has served as the steward of creative and digital strategy for biotech, pharma, device, and diagnostics clients and brands across marketing, medical affairs, and payer communications. As the president of HD, a full-service interactive agency and the digital/creative strategy and solutions hub for the Healthcare Consultancy Group (HCG) companies, he urges people to be thoughtful and bold when venturing into new technologies.

    From developing virtual and augmented reality for use at congresses and in the field, to robust multichannel personal and nonpersonal initiatives, he and his teams help clients choose the right technology and the right channels to communicate their brands’ unique scientific stories to key stakeholders to ensure effective engagement.

    Greg started his career in digital health care communications in 2000 at WorldMedicalLeaders.com, an Internet start-up company that provided online content to physicians, before joining HCG in 2002.









  • Elizabeth Robinson, EdM
    Executive Vice President, Director of Talent Engagement and Development, Healthcare Consultancy Group
    PHONE
    (212) 849-7708

    Elizabeth is passionate about creating transformative learning experiences. As a former client services executive, Elizabeth developed innovative educational initiatives for healthcare providers on behalf of many leading pharmaceutical companies. She now leverages her learning and leadership expertise to empower the Healthcare Consultancy Group's (HCG’s) individuals and teams to develop to their full potential and to support HCG’s continuing growth and development as a leading learning organization.

    Elizabeth earned her EdM in adult learning and leadership from Columbia University’s Teachers College. In her current role, she translates adult learning principles into practice with a special focus on adult development, team learning, organizational behavior, action learning, and leadership development. In addition, Elizabeth’s research as a doctoral candidate explores learning and performance within innovation teams.

    In her free time, Elizabeth can be found spending time with family and friends, taking nature walks with her husband and dog, practicing yoga, and binge-watching her latest favorite show.









  • Scott Roberts, MBA
    Executive Vice President, Managing Director, Provaluate
    PHONE
    (216) 378-8855

    Scott is EVP, managing director of Provaluate, a market access and early product planning consulting division of the Healthcare Consultancy Group (HCG). Scott has deep expertise in global market access and is passionate about helping clients find innovative solutions in categories where commercialization, pricing, and access have become highly complex. These include oncology, immunology, neurology, biosimilars, rare diseases, and gene therapies.

    He brings clients a balanced perspective, having spent time in top industry commercial and access-management roles with Biogen, Pharmacia, Roche, and Merck. He also has over 11 years of strategic consulting experience with HCG, PriceSpective, and the New England Consulting Group. As a consultant, Scott has worked on dozens of engagements with large and small biopharma companies to shape early drug development programs by aligning needs across R&D, regulatory, medical, commercial, and market access.

    Prior to rejoining HCG in early 2016, Scott spent 5 years as the head of global market access and pricing strategy with Biogen, launching major brands for neurodegenerative and hematologic diseases. In his time with Biogen he was instrumental in building cross-functional processes to elevate the understanding of market access inputs into early R&D decision-making.

    Scott earned his MBA from Boston University's Questrom School of Business Management, and BS degrees in biomechanical engineering and economics from Brown University.









  • Karl Simunic, MS
    President, Entwine
    PHONE
    +44 (208) 326-3177

    Karl joined the Healhcare Consultancy Group (HCG) in 2001 with a diverse background combining 3 distinct areas: engineering, marketing, and a creative pedigree from his early career experiences.

    He manages Entwine, a progressive, global, digital communications agency focused on scientific communications. Karl is responsible for business development strategy, innovation, and the evolution of new digital and creative products and services. His teams focus on digital transformation, evolution of digital ecosystems, and communication experiences, all designed to make interactions with science exciting and meaningful.

    Karl earned his MS degree in engineering from STU Bratislava, focusing on production and marketing information systems. He started his career as a designer, and later as an art director working in consumer advertising. After moving to New York he joined Health Science Communications, quickly rising to the position of creative director. In 2012, Karl joined Chameleon to further develop their creative and digital services offerings. The ensuing success in digital innovation and creative offerings led to the establishment of the Entwine brand as a digital communications agency of its own in 2016.

    In his current role, Karl highly values the opportunity to apply his diverse blend of experience to the creation and commercialization of unique data-based creative solutions, addressing scientific digital transformation needs, scientific brand activation, and healthcare communication challenges.

    Karl likes to keep on the move, whether it’s running, exercising, or commuting between the offices in the EU and US during the week and Luxembourg, where he spends most of his weekends with his family.









Careers

Join Us!

Across the globe, our people believe in and love what they do. If you want to challenge your mind and work with a group of passionate individuals, come and make a difference with us!

Explore Open Positions

Contact

Drop Us a Line

Healthcare Consultancy Group
488 Madison Avenue, 5th floor
New York, NY 10022

PHONE
(203) 992-6703

Matt D’Auria
Chief Executive Officer
Healthcare Consultancy Group

HCG
488 Madison Avenue
New York, NY 10022

Privacy Policy

Healthcare Consultancy Group

Healthcare Consultancy Group (“HCG”) recognizes the importance of your personal privacy. Therefore, we have created this Privacy Policy so that you know how we use and disclose your information when you make it available to us.

This Privacy Policy applies to: (1) a HCG website when the Privacy Policy appears as a hyperlink on such website (the "Website") and (2) HCG’s services which involve the collection of personally identifiable information from physicians in connection with projects for HCG’s clients (the “HCG Services”).

By using the Website or participating in the HCG Services, you signify your agreement to be bound by our Privacy Policy. IF YOU DO NOT AGREE TO THIS PRIVACY POLICY YOU MAY NOT USE OUR WEBSITE OR PARTICIPATE IN THE HCG SERVICES.

Personally Identifiable Information that we collect:

We do not collect personally identifiable information from you unless you voluntarily provide it to us, such as by signing up for a study, completing an inquiry form or otherwise choosing to share your personally identifiable information with us. The personally identifiable information which you may provide to us could include your name, email address, physical address and other personal information.

In connection with the HCG Services, the personally identifiable information may include information necessary for payment purposes.

Non-personal or Aggregate Information that we collect:

When you access our Website or use the HCG Services, we may automatically collect non-personally identifiable information from you, such as IP host address, web pages viewed, browser type, referring website, usage and browsing habits on the Website and similar data. We may also aggregate demographic information collected from our users (such as the number of users in a particular State) in a manner which does not identify any one individual. We may also aggregate information collected offline in connection with the Website or use the HCG Services, obtain non-personally identifiable information from third party sources and develop aggregate information by anonymizing previously collected personally identifiable information.

It is possible at times when collecting non-personally identifiable information through automatic means that we may unintentionally collect or receive personally identifiable information that is mixed in with the non-personally identifiable information. While we will make reasonable efforts to prevent such incidental data collection, the possibility still exists. If we do inadvertently collect personally identifiable information, we will not use such personally identifiable information as if we had collected it with your consent.

Information Usage:

We will only use your personally identifiable information as described below, unless you have specifically consented to another type of use, either at the time the personally identifiable information is collected from you or through some other form of consent from you:

  • We may share your personally identifiable information collected in connection with the HCG Services with the sponsor or HCG client who is identified by name in connection with a particular HCG Service in which you participate. Once your personally identifiable information has been provided to the sponsor or HCG client, HCG is no longer responsible for how such information is used by such party.
  • We may use your personally identifiable information to respond to your inquires or requests.
  • We may use your personally identifiable information to send you emails from time to time about our services, such as future studies, but we will not provide your personally identifiable information to third parties for them to contact you directly unless otherwise permitted by this Privacy Policy or you provide your consent.
  • We may permit our vendors and subcontractors to access your personally identifiable information, but they are only permitted to do so in connection with performing services for us. They are not authorized by us to use the information for their own benefit.
  • We may disclose personally identifiable information as required by law or legal process.
  • We may disclose personally identifiable information to investigate suspected fraud, harassment or other violations of any law, rule or regulation, or the terms or policies for our services or our sponsors.
  • We may transfer your personally identifiable information in connection with the sale or merger of HCG or the division responsible for the services with which your personally identifiable information is associated.
  • We may share your personally identifiable information with an affiliate of HCG who is in the same corporate family as us as long as their privacy practices are substantially similar to ours.

Non-personally identifiable or aggregate information may be shared with any number of parties, provided that such information shall not specifically identify you.

Cookies:

"Cookies" are pieces of information that may be placed on your computer by a website for the purpose of facilitating and enhancing your communication and interaction with that website. Many websites use cookies for these purposes. We may use cookies (and similar items such as clear gifs, web beacons, tags, etc…) on our Websites to customize your visit and for other purposes to make your visit more convenient or to enable us to enhance our service. In addition, our advertisers and business partners may set cookies and similar items on your computer when you use our Website. You may stop or restrict the placement of cookies on your computer or flush them from your browser by adjusting your web browser preferences, in which case you may still use our Website, but it may interfere with some of its functionality. Cookies and similar items are not used by us to automatically retrieve personally identifiable information from your computer without your knowledge.

Security:

The security of your personally identifiable information is very important to us. When we collect your personally identifiable information offline, we use reasonable efforts to protect it from unauthorized access. However, we cannot guarantee that your personally identifiable information will be completely free from unauthorized access by third parties such as hackers and your use of our Website and HCG Services demonstrates your assumption of this risk. We have put in place reasonable physical, electronic, and managerial procedures to safeguard the information we collect. Only those employees who need access to your information in order to perform their duties are authorized to have access to your personally identifiable information. For more information on protecting your privacy, please visit www.ftc.gov/privacy.

Your disclosures in blogs and other social media:

You should be aware that personally identifiable information which you voluntarily include and transmit online in a publicly accessible blog, chat room, social media platform or otherwise online, or that you share in an open forum such as an in-person panel or survey, may be viewed and used by others without any restrictions. We are unable to control such uses of your personally identifiable information, and by using such services you assume the risk that the personally identifiable information provided by you may be viewed and used by third parties for any number of purposes.

Protection for Children:

We have no intention of collecting personal information from children under the age of 13. When we become aware that personal information from a child under 13 has been collected without such child’s parent or guardian’s consent, we will use all reasonable efforts to delete such information from our database.

Other Websites:

As a convenience to you, we may provide links to third-party websites from within our Website. We are not responsible for the privacy practices or content of these third-party sites. When you link away from our Website, you do so at your own risk.

Changes to this Privacy Policy:

We reserve the right, at our discretion, to change, modify, add, or remove portions from this Privacy Policy at any time. However, if at any time in the future we plan to use personally identifiable information in a way that materially differs from this Privacy Policy, we will post such changes here and provide you the opportunity to opt-out of such differing uses. Your continued use of the Website and HCG Services following the posting of any changes to this Privacy Policy means you accept such changes.

Opt-Out Process:

All unsubscribe or opt-out requests should be sent to us at unsubscribe@hcg-int.com and we will process your request within a reasonable time after receipt. However, we are not responsible for removing your personally identifiable information from the lists of any third party who has previously been provided your information in accordance with this Privacy Policy or your consent, such as a sponsor. You should contact such third parties directly.

United States of America:

Our servers are maintained in the United States of America. By using the Website or participating in the HCG Services, you freely and specifically give us your consent to export your personally identifiable information to the USA and to store and use it in the USA as specified in this Privacy Policy.

Contact:

For questions or concerns relating to privacy, we can be contacted at: privacy@hcg-int.com.